Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial

Jerry Tsai; Anna L. Chien; Noori Kim; Saleh Rachidi; Brian M. Connolly; Hester Lim; Sabrina Sisto Alessi César; Sewon Kang; Luis A. Garza

doi:10.1016/j.jaad.2021.01.098

Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial

Jerry Tsai, Anna L. Chien, Noori Kim, Saleh Rachidi, Brian M. Connolly, Hester Lim, Sabrina Sisto Alessi César, Sewon Kang, Luis A. Garza

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1044-1046
Number of pages	3
Journal	Journal of the American Academy of Dermatology
Volume	85
Issue number	4
DOIs	https://doi.org/10.1016/j.jaad.2021.01.098
State	Published - Oct 2021

ASJC Scopus subject areas

Dermatology

Access to Document

10.1016/j.jaad.2021.01.098

Cite this

Tsai, J., Chien, A. L., Kim, N., Rachidi, S., Connolly, B. M., Lim, H., Alessi César, S. S., Kang, S., & Garza, L. A. (2021). Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial. Journal of the American Academy of Dermatology, 85(4), 1044-1046. https://doi.org/10.1016/j.jaad.2021.01.098

Tsai, J, Chien, AL, Kim, N, Rachidi, S, Connolly, BM, Lim, H, Alessi César, SS, Kang, S & Garza, LA 2021, 'Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial', Journal of the American Academy of Dermatology, vol. 85, no. 4, pp. 1044-1046. https://doi.org/10.1016/j.jaad.2021.01.098

@article{f421ad6f5ae5411e88aa784902836d7a,

title = "Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial",

author = "Jerry Tsai and Chien, {Anna L.} and Noori Kim and Saleh Rachidi and Connolly, {Brian M.} and Hester Lim and {Alessi C{\'e}sar}, {Sabrina Sisto} and Sewon Kang and Garza, {Luis A.}",

note = "Funding Information: Funding sources: Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases , part of the National Institutes of Health , under R01AR074846 01 and a grant from the National Rosacea Society to Dr Garza. This work was also supported by the Thomas Provost, MD Young Faculty Development Fund of Johns Hopkins Dermatology to Dr Garza. ",

year = "2021",

month = oct,

doi = "10.1016/j.jaad.2021.01.098",

language = "English (US)",

volume = "85",

pages = "1044--1046",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Topical timolol 0.5% gel-forming solution for erythema in rosacea

T2 - A quantitative, split-face, randomized, and rater-masked pilot clinical trial

AU - Tsai, Jerry

AU - Chien, Anna L.

AU - Kim, Noori

AU - Rachidi, Saleh

AU - Connolly, Brian M.

AU - Lim, Hester

AU - Alessi César, Sabrina Sisto

AU - Kang, Sewon

AU - Garza, Luis A.

N1 - Funding Information: Funding sources: Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases , part of the National Institutes of Health , under R01AR074846 01 and a grant from the National Rosacea Society to Dr Garza. This work was also supported by the Thomas Provost, MD Young Faculty Development Fund of Johns Hopkins Dermatology to Dr Garza.

PY - 2021/10

Y1 - 2021/10

UR - http://www.scopus.com/inward/record.url?scp=85103317044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103317044&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2021.01.098

DO - 10.1016/j.jaad.2021.01.098

M3 - Article

C2 - 33548303

AN - SCOPUS:85103317044

SN - 0190-9622

VL - 85

SP - 1044

EP - 1046

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 4

ER -

Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this